The European Federation for Medicinal Chemistry (EFMC) is an independent association representing medicinal chemistry societies in Europe. Its objective is to advance the science of medicinal chemistry by promoting cooperation and networking, by providing training and mentoring, by rewarding scientific excellence, and by facilitating communication and influencing stakeholders.

Meetings  January 2018 Next
  • 7th EuCheMS Chemistry Congress: Molecular Frontiers & Global Challenges

    2630 August, 2018   ACC LIVERPOOL, UK

    With a theme of ‘Molecular frontiers and global challenges’, the 7th EuCheMS Chemistry Congress features five days of scientific and technical sessions, plenary lectures, oral and poster communications, keynote speakers and roundtable discussions, as well as exceptional networking opportunities, an exhibition and a unique social programme.

    The EuCheMS Chemistry Congresses reflect the outstanding research being done in Europe and around the world by bringing together chemists from different countries and professional backgrounds to exchange ideas, advance knowledge and discuss key issues for chemistry and society. As such, the 7th EuCheMS Chemistry Congress offers you exceptional opportunities to network with chemists from across Europe and beyond.

    Organised by the European Association for Chemical and Molecular Sciences (EuCheMS) and the Royal Society of Chemistry (RSC).


Job portal

23/01/2018
Project in Dry Eye Disease Drug Development (IT-DED3) is seeking candidates for 12 Early Stage Researcher (ESR) positions across Europe, IT-DED3 Project, University of Antwerp: Medicinal Chemistry, Antwerp, Belgium
read more


12/01/2018
Synthetic Organic and Medicinal Chemists, Vernalis Research: Chemistry, Cambridge, United Kingdom
read more


20/04/2017
Medicinal / Synthetic Organic Chemists, Concept Life Sciences: Drug Discovery, Sandwich, Kent, United Kingdom
read more


Job portal page

Follow us on Facebook

Follow us on Twitter

Follow us on LinkedIn

ChemBridgeBoehringer IngelheimNovartisProf Dr W. Th. Nauta FoundationPfizerServierRoche
 Prous Institute for Biomedical ResearchUCBJanssen R&DBayerMerck